Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Powell

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
The Laryngoscope|June 29, 2019
Pediatric tracheostomy: A large single-center experienceJessica Roberts, Jason Powell, Jacob Begbie, et al.
Medical Oncology (Northwood, London, England)|March 8, 2021
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trialPeter Oppelt, Jessica Ley, Mackenzie Daly, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|December 30, 2020
Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008-2019)Kim Keltie, Adam Donne, Mat Daniel, et al.
The Lancet. Oncology|October 31, 2021
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trialChad Tang, Pavlos Msaouel, Kieko Hara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II StudyJoshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.
The Oncologist|May 13, 2017
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment OptionsLaurie M Gay, Sungeun Kim, Kyle Fedorchak, et al.
The Lancet. Oncology|February 10, 2020
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialMarina C Garassino, Shirish Gadgeel, Emilio Esteban, et al.
Thorax|February 22, 2023
Tracheostomy in children is associated with neutrophilic airway inflammationJason Powell, Steven Powell, Michael W Mather, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced MalignanciesBenedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, et al.
International Journal of Pediatric Otorhinolaryngology|October 1, 2024
A multicentre observational study of paediatric head and neck abscessesTimothy Davies, Anne Markey, Noor Janjua, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
The Laryngoscope|June 29, 2019
Pediatric tracheostomy: A large single-center experienceJessica Roberts, Jason Powell, Jacob Begbie, et al.
Medical Oncology (Northwood, London, England)|March 8, 2021
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trialPeter Oppelt, Jessica Ley, Mackenzie Daly, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|December 30, 2020
Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008-2019)Kim Keltie, Adam Donne, Mat Daniel, et al.
The Lancet. Oncology|October 31, 2021
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trialChad Tang, Pavlos Msaouel, Kieko Hara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II StudyJoshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.
The Oncologist|May 13, 2017
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment OptionsLaurie M Gay, Sungeun Kim, Kyle Fedorchak, et al.
The Lancet. Oncology|February 10, 2020
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialMarina C Garassino, Shirish Gadgeel, Emilio Esteban, et al.
Thorax|February 22, 2023
Tracheostomy in children is associated with neutrophilic airway inflammationJason Powell, Steven Powell, Michael W Mather, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced MalignanciesBenedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, et al.
International Journal of Pediatric Otorhinolaryngology|October 1, 2024
A multicentre observational study of paediatric head and neck abscessesTimothy Davies, Anne Markey, Noor Janjua, et al.
Pageof 9